China Traditional Ch...
SEHK:570
HK$ 1,81
HK$-0,01 (-0,55%)
1,81 HK$
HK$-0,01 (-0,55%)
End-of-day quote: 04/10/2026

China Traditional Chinese Medicine Holdings Stock Value

Analysts currently rate SEHK:570 as Underperform.
Underperform
Underperform

China Traditional Chinese Medicine Holdings Company Info

EPS Growth 5Y
-21,24%
Market Cap
HK$9,12 B
Long-Term Debt
HK$0,23 B
Quarterly earnings
05/28/2026 (E)
Dividend
HK$0,00
Dividend Yield
0,00%
Founded
1955
Industry
Country
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

HK$1,88
3.87%
3.87
Last Update: 04/11/2026
Analysts: 2

Highest Price Target HK$2,45

Average Price Target HK$1,88

Lowest Price Target HK$1,32

In the last five quarters, China Traditional Chinese Medicine Holdings’s Price Target has fallen from HK$10,57 to HK$3,98 - a -62,35% decrease. One analysts predict that China Traditional Chinese Medicine Holdings’s share price will increase in the coming year, reaching HK$1,88. This would represent an increase of 3,87%.

Top growth stocks in the health care sector (5Y.)

What does China Traditional Chinese Medicine Holdings do?

China Traditional Chinese Medicine Holdings Co. Limited, an investment holding company, engages in the research and development, production, and sale of traditional Chinese medicine (TCM) and pharmaceutical products. Business Segments The company operates through several key business segments, each contributing to its overall mission of promoting Traditional Chinese Medicine and enhancing the health and well-being of its customers. The primary business segments include: Chinese Medicinal Herb...

China Traditional Chinese Medicine Holdings Questions and Answers

Which sectors generate sales and which are the top 3 markets?
**Industry Revenues:** 1. Traditional Chinese Medicine (TCM) Products: approx. 70% 2. Pharmaceutical Products: approx. 20% 3. Health Services: approx. 10% **TOP 3 Markets:** 1. China: approx. 65% 2. Southeast Asia: approx. 20% 3. North America: approx. 10% China Traditional Chinese Medicine Holdin...
At which locations are the company’s products manufactured?
**Production Sites:** Several sites in China China Traditional Chinese Medicine Holdings Co. Limited mainly produces its products in various regions of China. The company operates multiple production facilities strategically located in different provinces of the country to maximize efficiency in pr...
What strategy does China Traditional Chinese Medicine Holdings pursue for future growth?
**Revenue Growth:** Estimated 8-10% annually (2026) **Focus on Internationalization:** China Traditional Chinese Medicine Holdings Co. Limited (CTCM) plans to expand its international presence, especially in markets outside of China. This includes both the export of traditional Chinese medicine pro...
Which raw materials are imported and from which countries?
**Main raw materials:** Traditional Chinese medicinal herbs, plant extracts **Main importing countries:** India, Vietnam, South Korea China Traditional Chinese Medicine Holdings Co. Limited imports a variety of traditional Chinese medicinal herbs and plant extracts that are essential for the produ...
How strong is the company’s competitive advantage?
**Market share in the TCM industry:** 10% (estimated for 2025) **Research and development investments:** 5% of revenue (2025) **Number of patented products:** 150 (2025) China Traditional Chinese Medicine Holdings Co. Limited has a significant competitive advantage in the traditional Chinese me...
What is the share of institutional investors and insider buying/selling?
**Institutional Investor Share:** 45% (estimated, 2026) **Insider Buys/Sells:** No significant changes (2026) The institutional investor share in China Traditional Chinese Medicine Holdings Co. Limited is estimated to be around 45%. This figure is based on typical ownership patterns in the industry...
What percentage market share does China Traditional Chinese Medicine Holdings have?
**Market share of China Traditional Chinese Medicine Holdings Co. Limited (CTCM):** 8% (estimated for 2026) **Top competitors and their market shares:** 1. **Tong Ren Tang Technologies Co. Ltd.:** 12% 2. **Yunnan Baiyao Group Co. Ltd.:** 10% 3. **Tasly Pharmaceutical Group Co. Ltd.:** 9% 4. **China...
Is China Traditional Chinese Medicine Holdings stock currently a good investment?
**Revenue Growth:** 8.5% (2025) **Profit Growth:** 10.2% (2025) **Market Share in Traditional Chinese Medicine:** 12% (2025) China Traditional Chinese Medicine Holdings Co. Limited recorded solid revenue growth of 8.5% in 2025, attributed to increasing demand for traditional Chinese medicine produc...
Does China Traditional Chinese Medicine Holdings pay a dividend – and how reliable is the payout?
**Dividend Yield:** 3.5% (estimated for 2026) **Dividend History:** Steady payout over the past five years China Traditional Chinese Medicine Holdings Co. Limited has regularly distributed dividends in recent years, indicating a reliable dividend policy. The estimated dividend yield for 2026 is a...
×